Cite
Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey.
MLA
Flower, Barnaby, et al. “Clinical and Laboratory Evaluation of SARS-CoV-2 Lateral Flow Assays for Use in a National COVID-19 Seroprevalence Survey.” Thorax, vol. 75, no. 12, Dec. 2020, pp. 1082–88. EBSCOhost, https://doi.org/10.1136/thoraxjnl-2020-215732.
APA
Flower, B., Brown, J. C., Simmons, B., Moshe, M., Frise, R., Penn, R., Kugathasan, R., Petersen, C., Daunt, A., Ashby, D., Riley, S., Atchison, C. J., Taylor, G. P., Satkunarajah, S., Naar, L., Klaber, R., Badhan, A., Rosadas, C., Khan, M., & Fernandez, N. (2020). Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey. Thorax, 75(12), 1082–1088. https://doi.org/10.1136/thoraxjnl-2020-215732
Chicago
Flower, Barnaby, Jonathan C. Brown, Bryony Simmons, Maya Moshe, Rebecca Frise, Rebecca Penn, Ruthiran Kugathasan, et al. 2020. “Clinical and Laboratory Evaluation of SARS-CoV-2 Lateral Flow Assays for Use in a National COVID-19 Seroprevalence Survey.” Thorax 75 (12): 1082–88. doi:10.1136/thoraxjnl-2020-215732.